Ozempic for After Bariatric Surgery: Evidence, Eligibility
Ozempic is not FDA approved for weight regain after bariatric surgery. It is approved for type 2 diabetes, heart risk and kidney disease in type 2 diabetes. Some doctors prescribe it when one of those uses also applies. In STEP 1, people on Wegovy lost 14.9% of body weight on average, vs 2.4% on placebo.
- Active ingredient
- semaglutide
- How it is taken
- weekly injection
- Approved for
- Type 2 diabetes, heart risk and kidney disease in type 2 diabetes
- Best result (STEP 1)
- 14.9% weight loss
Ozempic in brief
Its half-life is about 1 week: after 7 d, half is gone, and after five half-lives (35 d), about 3% remains.
In the SUSTAIN 1 trial of 30 weeks, people with type 2 diabetes lost 4.7 kg, compared with 1.2 kg on placebo.
The maker's price page lists monthly price points in US dollars for both the list price and self-pay offers.
Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.
Who qualifies?
| Who sets the rule | Who qualifies |
|---|---|
| FDA label | It lowers blood sugar in adults with type 2 diabetes when used with diet and exercise. |
| FDA label | Taking it lowers the risk of heart attack, stroke, or heart-related death for adults with type 2 diabetes and heart disease. |
| FDA label | When adults have type 2 diabetes along with chronic kidney disease, the risk drops for worsening kidney disease, kidney failure, and heart-related death. |
| Typical commercial plan (Aetna policy) | BMI 30 or higher |
| Typical commercial plan (Aetna policy) | BMI 27 or higher with a weight-related condition |
| Typical commercial plan (Aetna policy) | first comes a program of diet and activity lasting 6 months |
Sources: aetna.com and FDA label (DailyMed).
What the trials found after bariatric surgery
Every person studied was an adult with obesity or overweight who did not have diabetes. These trials did not enroll only people who regained weight after bariatric surgery.
| Trial | Medicine | Who took part | Length | People | Main result | Comparison |
|---|---|---|---|---|---|---|
| STEP 1 |  Wegovy | Adults with obesity or overweight, without diabetes | 68 weeks | 1,961 | 14.9% weight loss | 2.4% on placebo |
| OASIS 4 | Wegovy | Adults with obesity or overweight, without diabetes | 64 weeks | 307 | 13.6% weight loss | 2.4% on placebo |
Where the trial data comes from: STEP 1 (FDA label (DailyMed)).
What is different after bariatric surgery?
| What changes | What the label says |
|---|---|
| Acute Kidney Injury Due to Volume Depletion | Vomiting or diarrhea can cause fluid loss, which may lead to kidney injury. Drink fluids and report heavy fluid loss. |
| Severe Gastrointestinal Adverse Reactions | Stomach and gut side effects are common and may be severe. Not recommended for people with severe gastroparesis. |
| Acute Gallbladder Disease | Gallstones and gallbladder inflammation can happen. Report skin or eyes turning yellow, a fever, or pain in your upper right belly. |
| Taken with oral medicines | It slows the speed at which the stomach empties, and that can change how your body takes in other pills. |
Taken from the FDA labels: FDA label on DailyMed.
These label warnings come from the FDA label (DailyMed).
What is covered after bariatric surgery
Medicare Part D does not cover a GLP-1 prescribed for weight loss only.
Medicaid usually requires prior authorization for covered weight-loss GLP-1s.
Sources: humana.com, KFF.
- Ozempic Coupon
- Ozempic Cost
- Ozempic Cost Without Insurance
- Ozempic Cost With Insurance
- Is Ozempic Covered by Insurance? Criteria, Copay, Appeal
- Does Medicare Cover Ozempic? Part D Rules and the GLP-1 Bridge
- Ozempic Patient Assistance
- Cheapest Way to Get Ozempic
- Does Medicaid Cover Ozempic? Criteria, Copay, How to Appeal
Other choices after bariatric surgery
| Medicine | For life after bariatric surgery | How it is taken | Trial result |
|---|---|---|---|
| Ozempic | Not a listed use | weekly injection | Not listed |
| Wegovy | Not a listed use | weekly injection or daily tablet | 14.9% weight loss |
 Rybelsus | Not a listed use | daily tablet | Not listed |
 Mounjaro | Not a listed use | weekly injection | Not listed |
 Zepbound | Not a listed use | weekly injection | 20.9% weight loss |
 Foundayo | Not a listed use | daily tablet | 11.1% weight loss |
 Trulicity | Not a listed use | weekly injection | Not listed |
 Saxenda | Not a listed use | daily injection | 7.4% weight loss |
 Victoza | Not a listed use | daily injection | Not listed |
| Byetta | Not a listed use | twice-daily injection | Not listed |
Sources: FDA label (DailyMed).
Questions to ask your prescriber
- How soon after surgery can you safely start it?
- How will we handle nausea and fluids in our plan?
- Will my oral medicines still be absorbed well?
For full prescribing details, see Ozempic on DailyMed.